Subscribe to RSS
DOI: 10.1055/s-2006-950337
Synthesis and Regioselective N- and O-Alkylation of 1H- or 3H-[1,2,3]Triazolo[4,5-d]pyrimidine-5,7(4H,6H)-diones (8-Azaxanthines) and Transformation of Their 3-Alkyl Derivatives into 1-Alkyl Isomers
Publication History
Publication Date:
02 November 2006 (online)
Abstract
Several alkylating agents, for example alkyl halides and dimethyl sulfate, were employed in aprotic solvents under a variety of conditions for the alkylation of mono- and disubstituted 1H- or 3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-diones, which were prepared by cyclization of the appropriate 5,6-diaminouracils with nitrous acid. The alkylation on the triazole ring in the presence of anhydrous potassium carbonate took place simultaneously at the 1- and 2-positions, with alkylation at the 2-position taking priority. Similar alkylation on the pyrimidine ring with an equivalent alkylating reagent took place only at the 4-position. The alkylation of 3,6-disubstituted derivatives at room temperature led to 5-O-alkylation accompanied by 4-N-alkylation, but at high temperature only 4-N-alkylation took place. Reaction of 3,4,6-trisubstituted derivatives with excess alkylating agent at high temperature leads to the formation of 1,4,6-trisubstituted derivatives with elimination of the 3-substituent.
Key words
8-azaxanthines - triazolopyrimidines - regioselectivity - alkylations - heterocycles
-
1a
Smith KO.Galloway KS.Kennell WL.Ogilvie KK.Radatus BK. Antimicrob. Agents Chemother. 1982, 22: 55 -
1b
Smee DF.Martin JC.Verheyden JPH.Matthews TR. Antimicrob. Agents Chemother. 1983, 23: 676 -
1c
Bonnet PA.Robins RK. J. Med. Chem. 1993, 36: 635 -
1d
Qin X.Chen X.Wang K.Polin L.Kern ER.Drach JC.Gullen E.Cheng Y.-C.Zemlicka J. Bioorg. Med. Chem. 2006, 14: 1247 -
2a
Skipper HE.Montgomery JA.Thomson JR.Schabel FM. Cancer Res. 1959, 19: 425 -
2b
Skipper HE.Montgomery JA.Thomson JR.Schabel FM. Cancer Res. 1959, 19 (suppl.), part 2: 287 -
2c
Bowles WA.Schneider FH.Lewis LR.Robins RK. J. Med. Chem. 1963, 6: 471 -
2d
Kidder GW.Dewey VC.Parks RE.Woodside GL. Cancer Res. 1949, 11: 204 -
3a
Baker BR.Wood WF. J. Med. Chem. 1967, 10: 1101 -
3b
Baker BR.Wood WF.Kozma JA. J. Med. Chem. 1968, 11: 661 -
4a
Kim S.-A.Marshall MA.Melman N.Kim HS.Mueller CE.Linden J.Jacobson KA. J. Med. Chem. 2002, 45: 2131 -
4b
Daly JW.Padgett WL.Shamim MT. J. Med. Chem. 1986, 29: 1305 -
4c
Shimada J.Suzuki F.Nonaka H.Ishii A. J. Med. Chem. 1992, 35: 924 -
4d
Dooley MJ.Quinn RJ. Bioorg. Med. Chem. Lett. 1992, 2: 1199 -
4e
Miyamoto K.Takagi K.Sakai R.Wakusawa S.Koshiura R.Nadai M.Apichartpichean R.Hasegawa T. J. Pharm. Pharmacol. 1989, 41: 844 -
4f
Daly JW.Padgett W.Shamim MT.Butts-Lamb P.Waters J. J. Med. Chem. 1985, 28: 487 - 5
Daly JW. J. Med. Chem. 1982, 25: 197 -
6a
Yoneda F.Nagamatsu T. J. Chem. Soc., Perkin Trans. 1 1976, 1547 -
6b
Lister JH. Heterocycles 1977, 6: 383 -
6c
Hedayatullah M. J. Heterocycl. Chem. 1982, 19: 249 -
6d
Bram G.Decodts G.Bensaid Y.Farnoux CC.Galons H.Miocque M. Synthesis 1985, 543 -
6e
Mueller CE. Synth. Commun. 1994, 24: 1311 -
7a
Lee B.-H.Shin J.-H.Jang T.-S.Park J.-S.Kang S.-W. J. Korean Chem. Soc. 1997, 41: 357 -
7b
Coulson CJ.Ford RE.Lunt E.Marshall S.Pain DL.Rogers IH.Wooldridge KRH. Eur. J. Med. Chem. 1974, 9: 313 -
7c
Norris ER.Roush A. Arch. Biochem. 1950, 28: 465 -
8a
Ellison RE.Burchenal JH. Clin. Pharmacol. Ther. 1960, 1: 631 -
8b
Whittington RM.Rivers SL.Doyle RT.Kodlin D. Cancer Chemother. Rep. 1962, 18: 73 -
8c
Piro LD.Carrera CJ.Beutler E.Carson DA. Blood 1988, 72: 1069 -
8d
Parker WB.Secrist JA.Waud WR. Curr. Opin. Invest. Drugs 2004, 5: 592 -
8e
Kurtz J.-E.Andres E.Natarajan-Ame S.Noel E.Dufour P. Eur. J. Intern. Med. 2003, 14: 18 -
9a
Nagamatsu T.Yamasaki H.Akiyama T.Hara S.Mori K.Kusakabe H. Synthesis 1999, 655 -
9b
Nagamatsu T.Yamasaki H.Fujita T.Endo K.Machida H. J. Chem. Soc., Perkin Trans. 1 1999, 3117 -
9c
Nagamatsu T.Fujita T. Chem. Commun. 1999, 1461 -
9d
Nagamatsu T.Fujita T.Endo K. J. Chem. Soc., Perkin Trans. 1 2000, 33 -
9e
Nagamatsu T.Yamasaki H.Hirota T.Yamato M.Kido Y.Shibata M.Yoneda F. Chem. Pharm. Bull. 1993, 41: 362 -
9f
Nagamatsu T,Yamagishi Y, andYoneda F. inventors; Jpn. Kokai Tokkyo Koho, JP 09255681. ; Chem. Abstr. 1997, 127, 336635w -
9g
Nagamatsu T.Kuroda K.Mimura N.Yanada R.Yoneda F. J. Chem. Soc., Perkin Trans. 1 1994, 1125 -
9h
Nagamatsu T.Yamato H.Ono M.Takarada S.Yoneda F. J. Chem. Soc., Perkin Trans. 1 1992, 2101 -
9i
Nagamatsu T.Islam R. Heterocycles 2006, 68: 1811 - 10
Nübel G.Pfleiderer W. Chem. Ber. 1965, 98: 1060 - 11
Blicke FF.Godt HC. J. Am. Chem. Soc. 1954, 76: 2798 -
12a
Cresswell RM.Wood HCS. J. Chem. Soc. 1960, 4768 -
12b
Nübel G.Pfleiderer W. Chem. Ber. 1962, 95: 1605 -
12c
Pfleiderer W.Schundehutte K.-H. Justus Liebigs Ann. Chem. 1958, 612: 158 - 13
Bredereck H.Kupsch G.Wieland H. Chem. Ber. 1959, 92: 583 - 14
Senga K.Ichiba M.Nishigaki S. Heterocycles 1977, 6: 1915 - 15
Bozoova A.Rybar A.Alfoldi J.Basnakova G. Collect. Czech. Chem. Commun. 1992, 57: 1314 - 16
Fuksova K.Havlicek L.Krystof V.Lenobel R.Strnad M. PCT Int. Appl. 2004, 143 ; Chem. Abstr. 2004, 140, 217666 - 17
Blank HU.Wempen I.Fox JJ. J. Org. Chem. 1970, 35: 1131 - 18
Kokel B.Boussouira N. J. Heterocycl. Chem. 1987, 24: 1493